Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Long-sheng Chang"'
Autor:
Janet L. Oblinger, Jack Wang, Georgia D. Wetherell, Garima Agarwal, Tyler A. Wilson, Nicole R. Benson, Joelle M. Fenger, James R. Fuchs, A. Douglas Kinghorn, Long-Sheng Chang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Inhibition of translation initiation using eIF4A inhibitors like (−)-didesmethylrocaglamide [(−)-DDR] and (−)-rocaglamide [(−)-Roc] is a potential cancer treatment strategy as they simultaneously diminish multiple oncogenic drivers.
Externí odkaz:
https://doaj.org/article/9f51765470304068adff9d89398af258
Autor:
D. Bradley Welling, Katharine A. Collier, Sarah S. Burns, Janet L. Oblinger, Edina Shu, Beth A. Miles‐Markley, Craig C. Hofmeister, Mina S. Makary, H. Wayne Slone, Jaishri O. Blakeley, S. Alireza Mansouri, Brian A. Neff, Robert K. Jackler, Amir Mortazavi, Long‐Sheng Chang
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 1008-1019 (2021)
Abstract Objectives Two pilot studies of AR‐42, a pan‐histone deacetylase inhibitor, in human neurofibromatosis type 2 (NF2), vestibular schwannomas (VS), and meningiomas are presented. Primary endpoints included safety, and intra‐tumoral pharm
Externí odkaz:
https://doaj.org/article/ac95276f303d4f249c9f5ac8ec17ea8d
Autor:
Anusha Amaravathi, Janet L. Oblinger, D. Bradley Welling, A. Douglas Kinghorn, Long-Sheng Chang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The neurofibromatosis syndromes, including NF1, NF2, and schwannomatosis, are tumor suppressor syndromes characterized by multiple nervous system tumors, particularly Schwann cell neoplasms. NF-related tumors are mainly treated by surgery, and some o
Externí odkaz:
https://doaj.org/article/3619a9d037e049dcbaa7938cfc6cce89
Autor:
Long-Sheng Chang, Janet L Oblinger, Abbi E Smith, Marc Ferrer, Steven P Angus, Eric Hawley, Alejandra M Petrilli, Roberta L Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan K Bessler, Xiaohu Zhang, Rajarshi Guha, Craig Thomas, Sarah S Burns, Thomas S K Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A H Dixon, Andrea Masters, David R Jones, Charles W Yates, Stephen J Haggarty, Salvatore La Rosa, D Bradley Welling, Anat O Stemmer-Rachamimov, Scott R Plotkin, James F Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernandez-Valle, Gary L Johnson, Jaishri O Blakeley, D Wade Clapp, Synodos for NF2 Consortium
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0252048 (2021)
Neurofibromatosis Type 2 (NF2) is an autosomal dominant genetic syndrome caused by mutations in the NF2 tumor suppressor gene resulting in multiple schwannomas and meningiomas. There are no FDA approved therapies for these tumors and their relentless
Externí odkaz:
https://doaj.org/article/d5cdd322a442449ebaffcbfad82ea6a3
Autor:
Synodos for NF2 Consortium, Robert Allaway, Steve P Angus, Roberta L Beauchamp, Jaishri O Blakeley, Marga Bott, Sarah S Burns, Annemarie Carlstedt, Long-Sheng Chang, Xin Chen, D Wade Clapp, Patrick A Desouza, Serkan Erdin, Cristina Fernandez-Valle, Justin Guinney, James F Gusella, Stephen J Haggarty, Gary L Johnson, Salvatore La Rosa, Helen Morrison, Alejandra M Petrilli, Scott R Plotkin, Abhishek Pratap, Vijaya Ramesh, Noah Sciaky, Anat Stemmer-Rachamimov, Tim J Stuhlmiller, Michael E Talkowski, D Bradley Welling, Charles W Yates, Jon S Zawistowski, Wen-Ning Zhao
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197350 (2018)
Neurofibromatosis 2 (NF2) is a rare tumor suppressor syndrome that manifests with multiple schwannomas and meningiomas. There are no effective drug therapies for these benign tumors and conventional therapies have limited efficacy. Various model syst
Externí odkaz:
https://doaj.org/article/9827869b05b5455bb1789d9f8c1987f8
Autor:
Cristina Fernandez-Valle, Maria Clara Franco, Long-Sheng Chang, Fred F. Telischi, Xue Zhong Liu, Alicja J. Copik, Julia N. Soulakova, Rulong Shen, Rahul Mittal, Denise Yan, Olena Bracho, Christine T. Dinh, Sarah S. Burns, Stephani Klingeman Plati, Marisa A. Fuse
Neurofibromatosis type 2 (NF2) is a nervous system tumor disorder caused by inactivation of the merlin tumor suppressor encoded by the NF2 gene. Bilateral vestibular schwannomas are a diagnostic hallmark of NF2. Mainstream treatment options for NF2-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2082edda612e31101b4c151aaef003
https://doi.org/10.1158/1535-7163.c.6538786.v1
https://doi.org/10.1158/1535-7163.c.6538786.v1
Autor:
Jerry M. Collins, A. Douglas Kinghorn, Barry R. O'Keefe, Ryan D. Roberts, Yulin Ren, Garima Agarwal, Li Pan, Rulong Shen, Melinda G. Hollingshead, Larry W. Anderson, Jie Huang, Sarah S. Burns, Janet L. Oblinger, Long-Sheng Chang
Supplementary Figures S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f01b293f603c87646c57ab3bc17ccf
https://doi.org/10.1158/1535-7163.22519201
https://doi.org/10.1158/1535-7163.22519201
Autor:
Cristina Fernandez-Valle, Maria Clara Franco, Long-Sheng Chang, Fred F. Telischi, Xue Zhong Liu, Alicja J. Copik, Julia N. Soulakova, Rulong Shen, Rahul Mittal, Denise Yan, Olena Bracho, Christine T. Dinh, Sarah S. Burns, Stephani Klingeman Plati, Marisa A. Fuse
All supplementary data - four figures and supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89058016f44c9a449071bff09a3eb168
https://doi.org/10.1158/1535-7163.22507780.v1
https://doi.org/10.1158/1535-7163.22507780.v1
Autor:
Jerry M. Collins, A. Douglas Kinghorn, Barry R. O'Keefe, Ryan D. Roberts, Yulin Ren, Garima Agarwal, Li Pan, Rulong Shen, Melinda G. Hollingshead, Larry W. Anderson, Jie Huang, Sarah S. Burns, Janet L. Oblinger, Long-Sheng Chang
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53ab73f48c56d43839822caa9ecbbc0
https://doi.org/10.1158/1535-7163.22519198.v1
https://doi.org/10.1158/1535-7163.22519198.v1
Autor:
Long-Sheng Chang, D. Bradley Welling, Abraham Jacob, Ching-Shih Chen, Volker Senner, Jie Huang, Matthew L. Bush, Janet L. Oblinger, Elena M. Akhmametyeva, Sarah S. Burns
PDF file - 1.6MB, S1. The predicted truncated merlin protein was not detected in Ben-Men-1 cells. S2. IC50 determination of AR-42 in normal meningeal cells. S3. AR-42 treatment increased protein acetylation and decreased p-AKT. S4. Normal meningeal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ff3903d9e917532ec8b9c82aacef3f
https://doi.org/10.1158/0008-5472.22399977
https://doi.org/10.1158/0008-5472.22399977